XML 114 R83.htm IDEA: XBRL DOCUMENT
v3.26.1

Share-based payments - Disclosure of reconciliation of AGAs (Details) - shares |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 Months Ended | 6 Months Ended | 10 Months Ended | 12 Months Ended | 30 Months Ended
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Nov. 13, 2025 | Aug. 01, 2025 | May 30, 2025 | Mar. 20, 2025 | Feb. 06, 2025 | Sep. 05, 2024 | Jul. 11, 2024 | May 23, 2024 | Mar. 28, 2024 | Jan. 02, 2024 | Dec. 01, 2023 | Sep. 28, 2023 | Jul. 11, 2023 | Mar. 31, 2025 | Dec. 31, 2023 | Nov. 30, 2025 | Dec. 31, 2025 | Dec. 31, 2025
Total AGAs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments outstanding, beginning balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3,388,040 |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,601,296 |  | 6,280,727 | 10,828,148
Number of instruments lapsed (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (645,375) |
Number of instruments exercised (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (627,714) |
Number of instruments outstanding, ending balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 8,395,678 | 8,395,678
AGA-2023-1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments outstanding, beginning balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 780,040 |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  |  |  | 1,382,796 |  |  |  | 0 |
Number of instruments lapsed (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments exercised (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (230,464) |
Number of instruments outstanding, ending balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 549,576 | 549,576
AGA-2023-2 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments outstanding, beginning balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 75,000 |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  |  |  | 100,000 |  |  |  | 0 |
Number of instruments lapsed (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (75,000) |
Number of instruments exercised (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments outstanding, ending balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 0
AGA-2023-3 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments outstanding, beginning balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 485,875 |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  |  | 731,500 |  |  |  |  | 0 |
Number of instruments lapsed (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (34,750) |
Number of instruments exercised (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (251,125) |
Number of instruments outstanding, ending balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 200,000 | 200,000
AGA-2023-4 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments outstanding, beginning balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 213,250 |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  |  | 254,250 |  |  |  |  | 0 |
Number of instruments lapsed (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (15,000) |
Number of instruments exercised (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (108,500) |
Number of instruments outstanding, ending balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 89,750 | 89,750
AGA-2023-5 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments outstanding, beginning balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 81,250 |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  |  | 132,750 |  |  |  |  |  | 0 |
Number of instruments lapsed (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (26,000) |
Number of instruments exercised (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (27,625) |
Number of instruments outstanding, ending balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 27,625 | 27,625
AGA-2024-1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments outstanding, beginning balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,355,625 |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  |  | 1,549,125 |  |  |  |  |  |  | 0 |
Number of instruments lapsed (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (134,125) |
Number of instruments exercised (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments outstanding, ending balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,221,500 | 1,221,500
AGA-2024-2 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments outstanding, beginning balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 22,500 |
Number of instruments issued (in shares) |  |  |  |  |  |  |  |  | 22,500 |  |  |  |  |  |  |  | 0 |
Number of instruments lapsed (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments exercised (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments outstanding, ending balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 22,500 | 22,500
AGA-2024-3 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments outstanding, beginning balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 38,500 |
Number of instruments issued (in shares) |  |  |  |  |  |  |  | 38,500 |  |  |  |  |  |  |  |  | 0 |
Number of instruments lapsed (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (13,000) |
Number of instruments exercised (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments outstanding, ending balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 25,500 | 25,500
AGA-2024-4 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments outstanding, beginning balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 93,000 |
Number of instruments issued (in shares) |  |  |  |  |  |  | 93,000 |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments lapsed (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments exercised (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments outstanding, ending balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 93,000 | 93,000
AGA-2024-5 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments outstanding, beginning balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 25,000 |
Number of instruments issued (in shares) |  |  |  |  |  |  | 25,000 |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments lapsed (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments exercised (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments outstanding, ending balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 25,000 | 25,000
AGA-2024-6 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments outstanding, beginning balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 20,000 |
Number of instruments issued (in shares) |  |  |  |  |  |  | 20,000 |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments lapsed (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments exercised (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (10,000) |
Number of instruments outstanding, ending balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 10,000 | 10,000
AGA-2024-7 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments outstanding, beginning balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 198,000 |
Number of instruments issued (in shares) |  |  |  |  |  | 198,000 |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments lapsed (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments exercised (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments outstanding, ending balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 198,000 | 198,000
AGA-2025-1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments outstanding, beginning balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments issued (in shares) |  |  |  |  | 4,319,500 |  |  |  |  |  |  |  |  |  |  | 4,319,500 | 4,319,500 |
Number of instruments lapsed (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (217,500) |
Number of instruments exercised (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments outstanding, ending balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4,102,000 | 4,102,000
AGA-2025-2 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments outstanding, beginning balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments issued (in shares) |  |  |  |  | 123,102 |  |  |  |  |  |  |  |  |  |  | 123,102 | 123,102 |
Number of instruments lapsed (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments exercised (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments outstanding, ending balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 123,102 | 123,102
AGA-2025-3 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments outstanding, beginning balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments issued (in shares) |  |  |  |  | 17,625 |  |  |  |  |  |  |  |  |  |  | 17,625 | 17,625 |
Number of instruments lapsed (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments exercised (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments outstanding, ending balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 17,625 | 17,625
AGA-2025-4 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments outstanding, beginning balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments issued (in shares) |  |  |  |  | 30,500 |  |  |  |  |  |  |  |  |  |  | 30,500 | 30,500 |
Number of instruments lapsed (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments exercised (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments outstanding, ending balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 30,500 | 30,500
AGA-2025-5 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments outstanding, beginning balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments issued (in shares) |  |  |  | 50,000 |  |  |  |  |  |  |  |  |  | 50,000 |  | 50,000 | 50,000 |
Number of instruments lapsed (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (50,000) |
Number of instruments exercised (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments outstanding, ending balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 0
AGA-2025-6 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments outstanding, beginning balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments issued (in shares) |  |  | 25,000 |  |  |  |  |  |  |  |  |  |  |  |  | 25,000 | 25,000 |
Number of instruments lapsed (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments exercised (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments outstanding, ending balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 25,000 | 25,000
AGA-2025-7 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments outstanding, beginning balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments issued (in shares) |  | 1,711,000 |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,711,000 | 1,711,000 |
Number of instruments lapsed (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (80,000) |
Number of instruments exercised (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments outstanding, ending balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,631,000 | 1,631,000
AGA-2025-8 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments outstanding, beginning balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments issued (in shares) | 4,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4,000 | 4,000 |
Number of instruments lapsed (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments exercised (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 |
Number of instruments outstanding, ending balance (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4,000 | 4,000

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 47 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_47_b&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) expired in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_FreeSharesAGAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20231Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20232Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20233Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20234Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20235Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20241Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20242Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20243Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20244Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20245Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20246Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20247Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20251Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20252Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20253Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20254Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20255Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20256Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20257Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=abvx_AGA20258Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |